Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02096198 · ClinicalTrials.gov registry record

Ceramic On Ceramic (COC) 36mm PAS IDE Rollover Subjects; Ceramic Acetabular Bearing With Ceramic Femoral Head in Total Hip Replacement

A clinical trial of Osteoarthritis and Avascular Necrosis, sponsored by DePuy Orthopaedics.

Completed
Registry status
81
Enrollment target
5
Study locations

NCT02096198: Completed study of Osteoarthritis and Avascular Necrosis, sponsored by DePuy Orthopaedics.

NCT02096198 is a study of Osteoarthritis and Avascular Necrosis that has completed, run by DePuy Orthopaedics. The registered enrollment target is 81 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (90% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02096198, a study of Osteoarthritis and Avascular Necrosis, has completed, sponsored by DePuy Orthopaedics.

COMPLETED
Registry status
81 participants
Enrollment target
5
Study locations

Study Summary

This study is intended to gather medium (5- to 7-years) and long-term (minimum 8- to 10-years) information regarding the performance and safety of the commercially available 36mm CERAMAX® Ceramic on Ceramic (COC) Total Hip System from a cohort of study subjects that were previously enrolled in the IDE study. (COC = 36mm ceramic acetabular bearing insert component that articulates with a ceramic femoral head in the COC total hip replacement system)

Primary Outcome

Device survivorship will be estimated with a Kaplan-Meier survivorship analysis at 10-years post-operatively.

Conditions Studied

Osteoarthritis Avascular Necrosis Non-inflammatory Degenerative Joint Disease Post-Traumatic Osteoarthritis of Hip

Study Locations (5)

California

  • - Sacramento

Colorado

  • - Denver

North Carolina

  • - Winston-Salem

Ohio

  • Orthopedic One - Columbus

Virginia

  • - Alexandria

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2014-01-01
Est. Completion 2018-08-20
DePuy Orthopaedics

38 total trials

What the finished NCT02096198 record still lists

NCT02096198 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (90% lower).

The record links to 4 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 0 interventions.

NCT02096198 lists 5 locations in 5 states (California, Colorado, North Carolina).

Frequently Asked Questions

What is clinical trial NCT02096198 about?

NCT02096198 is a clinical study titled "Ceramic On Ceramic (COC) 36mm PAS IDE Rollover Subjects; Ceramic Acetabular Bearing With Ceramic Femoral Head in Total Hip Replacement". This study is intended to gather medium (5- to 7-years) and long-term (minimum 8- to 10-years) information regarding the performance and safety of the commercially available 36mm CERAMAX® Ceramic on Ceramic (COC) Total Hip System from a cohort of study subjects that were previously enrolled in the I...

What is the current status of trial NCT02096198?

This trial is currently completed. The enrollment target is 81 participants. The study started on 2014-01-01. Estimated completion is 2018-08-20.

What conditions does trial NCT02096198 study?

This clinical trial studies the following conditions: Osteoarthritis, Avascular Necrosis, Non-inflammatory Degenerative Joint Disease, Post-Traumatic Osteoarthritis of Hip.

Who is sponsoring clinical trial NCT02096198?

This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02096198 being conducted?

This trial has 5 study locations across California, Colorado, North Carolina, Ohio, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02096198's enrollment target sits among peer trials

81 98th of 135 higher than 38 of 135 other Osteoarthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04966481 · 81 participants · Phase 3

    Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor

  • NCT05109429 · 81 participants · NA

    Developing a Clinical Outcome Assessment for Opioid Craving

  • NCT05112601 · 81 participants · Phase 2

    Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

  • NCT05305911 · 81 participants · Phase 2

    Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT02096198, the US trial registry maintained by the National Library of Medicine. NCT02096198 (small enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.